Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

Investigator Insights

Evaluating Prophylactic Anticoagulant Therapy Effectiveness for Treating COVID-19

Topic: Infectious Diseases
Date: 09/17/2021

Christopher Rentsch, PhD In this episode, Dr. Christopher Rentsch, of the London School of Hygiene and Tropical Medicine and Yale University, talks about a large-scale evaluation of the effectiveness of prophylactic anticoagulant therapy for the treatment of COVID-19.

Since the recording of this podcast, the largest trial to date, ACTIV-4, has found that initiating therapeutic anticoagulation compared to prophylactic anticoagulation provided additional benefit among patients hospitalized with COVID-19. Both Dr. Rentsch’s study and the ACTIV-4 study found benefit in noncritically ill patients yet not in critically ill patients.

Listen (17:35)

Subscribe: iTunes   Google Play   XML


Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.